Tokyo, June 4 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061776) titled 'A Prospective Multicenter Study of Exploring Genomic Correlates of Clinical ... Read More
Tokyo, June 4 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061775) titled 'Safety of conservative follow-up for asymptomatic Kommerell diverticulum' on... Read More
Tokyo, June 4 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061773) titled 'Effect of Daily Ingestion of Difructose Anhydride III (DFA III) on Visceral ... Read More
Tokyo, June 4 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061770) titled 'Exploratory Study on the Dose-Dependent Efficacy and Functional Effects of L... Read More
Tokyo, June 4 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061768) titled 'Clinical Utility of a 24-Hour Home Blood Pressure Management System Using a ... Read More
Tokyo, June 4 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061762) titled 'A study of the usability of the 7-day DentalGO web application for adults wh... Read More
Tokyo, June 4 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061626) titled 'Effectiveness of Health Information and Visualization for Workers' on June 3... Read More
Singapore, June 2 -- The Health Sciences Authority received information related to the study titled 'A Global, Multicenter, Prospective, Controlled, Open-Label Pivotal Study of Iodofalan (131I) Soluti... Read More
Singapore, June 2 -- The Health Sciences Authority received information related to the study titled 'RASolute 303: A Phase 3 Global, Multicenter, Open-label, Randomized, 3-Arm Study of Daraxonrasib Mo... Read More
Singapore, June 2 -- The Health Sciences Authority received information related to the study titled 'A Multicenter, Multi-Part, Phase 1/2 Study of EIK1005 as Monotherapy and in Combination with Pembro... Read More